Immediate Versus Delayed Radical Prostatectomy: Updated Outcomes Following Active Surveillance of Prostate Cancer

被引:44
|
作者
Filippou, Pauline [1 ]
Welty, Christopher J. [1 ]
Cowan, Janet E. [1 ]
Perez, Nannette [1 ]
Shinohara, Katsuto [1 ]
Carroll, Peter R. [1 ]
机构
[1] Univ Calif San Francisco, Dept Urol, UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA
关键词
Active surveillance; Outcomes; Pathology; Prostate cancer; Radical prostatectomy; LOW-RISK; MEN; STRAIGHTFORWARD; RECURRENCE; COHORT; TRENDS; SCORE;
D O I
10.1016/j.eururo.2015.06.011
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Biopsy progression on active surveillance (AS) for prostate cancer (PCa) often reflects failure of the initial biopsy to detect cancer present at enrollment. The risks for delayed treatment among men who progress on AS are not well defined. Objective: To report outcomes for men who underwent surgery after AS compared to men who underwent immediate surgery and the influence of selection bias on this outcome. Design, setting, and participants: AS-eligible (ASE) men who underwent radical prostatectomy (RP) after a median of 20 mo of AS were compared to ASE men who underwent RP within 6 mo of diagnosis. A subset of men on AS who underwent RP after upgrade to Gleason 3 + 4 was compared to matched controls with similar pretreatment biopsy features who underwent immediate RP. Outcome measurement and statistical analysis: Rates of adverse pathology (upstaging, positive surgical margin, or Gleason upgrading) were examined. Logistic regression was used to determine associations between treatment subgroup and adverse pathology. Results and limitations: Of 157 ASE men who underwent delayed RP after AS, 54 were upgraded to Gleason 3 + 4 before surgery. ASE men who underwent immediate RP had lower probability of adverse pathology than ASE men who underwent delayed RP (hazard ratio [HR] 0.34, 95% confidence interval [CI] 0.21-0.55). The rate of adverse pathology did not differ between immediate and delayed RP patients matched for pretreatment characteristics (HR 0.79, 95% CI 0.27-2.28). The observational design of this study is its main limitation. Conclusions: When compared to men with similar pretreatment biopsy features, those who underwent delayed RP were not at higher risk of adverse pathology. Patient summary: The oncologic safety of delayed treatment when indicated for men enrolled in active surveillance for prostate cancer is important. We found that men who underwent delayed surgery had similar outcomes to men who underwent immediate prostatectomy. (C) 2015 European Association of Urology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:458 / 463
页数:6
相关论文
共 50 条
  • [31] Impact of a family history of prostate cancer on clinicopathologic outcomes and survival following radical prostatectomy
    Westerman, Mary E.
    Gershman, Boris
    Karnes, R. Jeffrey
    Thompson, R. Houston
    Rangel, Laureano
    Boorjian, Stephen A.
    WORLD JOURNAL OF UROLOGY, 2016, 34 (08) : 1115 - 1122
  • [32] Pathological findings at radical prostatectomy in patients initially managed by active surveillance: A comparative analysis
    Iremashvili, Viacheslav
    Manoharan, Murugesan
    Rosenberg, Daniel L.
    Acosta, Kristell
    Soloway, Mark S.
    PROSTATE, 2012, 72 (14) : 1573 - 1579
  • [33] Does cumulative prostate cancer length (CCL) in prostate biopsies improve prediction of clinically insignificant cancer at radical prostatectomy in patients eligible for active surveillance?
    Chen, Derrick J.
    Falzarano, Sara M.
    McKenney, Jesse K.
    Przybycin, Chris G.
    Reynolds, Jordan P.
    Roma, Andres
    Jones, J. Stephen
    Stephenson, Andrew
    Klein, Eric
    Magi-Galluzzi, Cristina
    BJU INTERNATIONAL, 2015, 116 (02) : 220 - 229
  • [34] Use of mpMRI in active surveillance for localized prostate cancer
    Scarpato, Kristen R.
    Barocas, Daniel A.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2016, 34 (07) : 320 - 325
  • [35] The influence of hepatic function on prostate cancer outcomes after radical prostatectomy
    Banez, L. L.
    Loftis, R. M.
    Freedland, S. J.
    Presti, J. C., Jr.
    Aronson, W. J.
    Amling, C. L.
    Kane, C. J.
    Terris, M. K.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2010, 13 (02) : 173 - 177
  • [36] Functional outcomes of robot-assisted radical prostatectomy in patients eligible for active surveillance
    Marc Zanaty
    Khaled Ajib
    Kevin Zorn
    Assaad El-Hakim
    World Journal of Urology, 2018, 36 : 1391 - 1397
  • [37] Pathological, Oncologic and Functional Outcomes of Radical Prostatectomy Following Active Surveillance
    Satkunasivam, Raj
    Kulkarni, Girish S.
    Zlotta, Alexander R.
    Kalnin, Robin
    Trachtenberg, John
    Fleshner, Neil E.
    Hamilton, Robert J.
    Jewett, Michael A. S.
    Finelli, Antonio
    JOURNAL OF UROLOGY, 2013, 190 (01) : 91 - 95
  • [38] Delayed radical prostatectomy for intermediate-risk prostate cancer is associated with biochemical recurrence: Possible implications for active surveillance from the SEARCH database
    Abern, Michael R.
    Aronson, William J.
    Terris, Martha K.
    Kane, Christopher J.
    Presti, Joseph C., Jr.
    Amling, Christopher L.
    Freedland, Stephen J.
    PROSTATE, 2013, 73 (04) : 409 - 417
  • [39] Active surveillance in favorable intermediate risk prostate cancer: outstanding questions and controversies
    Russell, J. Ryan
    Siddiqui, M. Minhaj
    CURRENT OPINION IN ONCOLOGY, 2022, 34 (03) : 219 - 227
  • [40] Outcomes of active surveillance for Japanese patients with prostate cancer (PRIAS-JAPAN)
    Kato, Takuma
    Matsumoto, Ryuji
    Yokomizo, Akira
    Tohi, Yoichiro
    Fukuhara, Hiroshi
    Fujii, Yoichi
    Mori, Keiichiro
    Sato, Takuma
    Inokuchi, Junichi
    Hashine, Katsuyoshi
    Sakamoto, Shinichi
    Kinoshita, Hidefumi
    Inoue, Koji
    Tanikawa, Toshiki
    Utsumi, Takanobu
    Goto, Takayuki
    Hara, Isao
    Okuno, Hiroshi
    Kakehi, Yoshiyuki
    Sugimoto, Mikio
    BJU INTERNATIONAL, 2024, 134 (04) : 652 - 658